【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Insulin Delivery Overview 7
3 Products under Development 8
3.1 Insulin Delivery – Pipeline Products by Stage of Development 8
3.2 Insulin Delivery – Pipeline Products by Segment 9
3.3 Insulin Delivery – Pipeline Products by Territory 10
3.4 Insulin Delivery – Pipeline Products by Regulatory Path 11
3.5 Insulin Delivery – Pipeline Products by Estimated Approval Date 12
3.6 Insulin Delivery – Ongoing Clinical Trials 13
4 Insulin Delivery – Pipeline Products under Development by Companies 14
4.1 Insulin Delivery Companies – Pipeline Products by Stage of Development 14
4.2 Insulin Delivery – Pipeline Products by Stage of Development 16
5 Insulin Delivery Companies and Product Overview 17
5.1 Amrita Vishwa Vidyapeetham Company Overview 17
5.1.1 Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview 17
5.2 Andain, Inc Company Overview 18
5.2.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.3 AstraZeneca PLC Company Overview 20
5.3.1 AstraZeneca PLC Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 Becton, Dickinson and Company Company Overview 22
5.4.1 Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 Cellnovo Ltd. Company Overview 24
5.5.1 Cellnovo Ltd. Pipeline Products & Ongoing Clinical Trials Overview 24
5.6 CeQur SA Company Overview 26
5.6.1 CeQur SA Pipeline Products & Ongoing Clinical Trials Overview 26
5.7 Companion Medical Company Overview 29
5.7.1 Companion Medical Pipeline Products & Ongoing Clinical Trials Overview 29
5.8 ConvaTec Healthcare B S.a.r.l. Company Overview 30
5.8.1 ConvaTec Healthcare B S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview 30
5.9 Dance Biopharm Inc. Company Overview 31
5.9.1 Dance Biopharm Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.10 Debiotech S.A. Company Overview 32
5.10.1 Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 32
5.11 InsuLenz Company Overview 37
5.11.1 InsuLenz Pipeline Products & Ongoing Clinical Trials Overview 37
5.12 Insulet Corporation Company Overview 38
5.12.1 Insulet Corporation Pipeline Products & Ongoing Clinical Trials Overview 38
5.13 InsuLine Medical Ltd. Company Overview 40
5.13.1 InsuLine Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40
5.14 LifeScan, Inc. Company Overview 45
5.14.1 LifeScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
5.15 Medical International Technologies (Mit Canada) Inc. Company Overview 47
5.15.1 Medical International Technologies (Mit Canada) Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.16 MedSolve Technologies, Inc. Company Overview 49
5.16.1 MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.17 MicroPort Scientific Corporation Company Overview 50
5.17.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 50
5.18 North Carolina State University Company Overview 52
5.18.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 52
5.19 Sanofi Company Overview 54
5.19.1 Sanofi Pipeline Products & Ongoing Clinical Trials Overview 54
5.20 SFC Fluidics LLC Company Overview 56
5.20.1 SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 56
5.21 Spring Health Solutions Ltd. Company Overview 57
5.21.1 Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 57
5.22 Transdermal Specialties, Inc. Company Overview 59
5.22.1 Transdermal Specialties, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.23 University of KwaZulu-Natal Company Overview 60
5.23.1 University of KwaZulu-Natal Pipeline Products & Ongoing Clinical Trials Overview 60
5.24 University of Toronto Company Overview 61
5.24.1 University of Toronto Pipeline Products & Ongoing Clinical Trials Overview 61
5.25 Ypsomed Holding AG Company Overview 62
5.25.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 62
6 Insulin Delivery- Recent Developments 64
7 Appendix 194
7.1 Methodology 194
7.2 About GlobalData 196
7.3 Contact Us 196
7.4 Disclaimer 196
【レポート販売概要】
■ タイトル：世界におけるインスリン送達デバイスの製品パイプライン動向2015■ 英文：Insulin Delivery - Pipeline Review, 2015
■ 発行日：2015年5月25日
■ 調査会社：GlobalData
■ 商品コード：GDME0011EPD
■ 調査対象地域：グローバル
- 痛風治療薬の世界市場2016-2020Gout is one type of arthritis, which is caused by the high levels of uric acid in the blood. The main symptoms of gout are sudden attack of burning pain, swelling in a joint, and stiffness, usually in toe. If it is not treated, over time, it can harm tendons, joints, and other tissues. NSAIDs and urate-lowering agents are preferred treatment options for gout. Technavio’s analysts forecast the glob …
- 自動車テレマティクス市場分析：Analyzing Automotive TelematicsThe advent of any technology always brings with itself an equally strong supporting wave of academic study on the safety, ease of usage and enhancement of convenience of that technology in human usage arena. The application of this approach to automotive usage is known as Automotive Telematics (AT). AT is an integrated platform of mobile, in-vehicle computing and wireless technologies which provid …
- 難燃剤の世界市場：三水和アルミナ（ATH）、酸化アンチモン、臭素系、塩素系、リン系Flame retardants are key components used in reducing the devastating effect of fire mishaps on people, property, and the environment. Most common elements used as flame retardants are bromine, chlorine, and phosphorous. The compounds of these elements are added to or treat potentially flammable materials. Flame retardants stop the fire by interacting with the fire cycle in the gaseous phase and st …
- 衛星M2M通信・サービスの世界市場2016-2020About Satellite M2M Technology Satellite M2M technology enables communication of data or information between electronic devices with the help of satellite networks. Satellite M2M is widely adopted in regions where cellular networks are not available, or their reach is limited. Oil and gas firms, enterprises, and government organizations worldwide are adopting satellite M2M due to its wide reach an …
- 大麻検査の世界市場予測（～2021）The global cannabis testing market is expected to reach USD 1,416.3 Million by 2021 from USD 822.0 Million in 2016, at a CAGR of 11.5% during the forecast period (2016–2021). The growth in this market is mainly driven by factors such as legalization of medical cannabis, coupled with the growing number of cannabis testing laboratories (specifically in the U.S.); growing adoption of LIMS in cannabis …
- フランスの患者診察機器市場見通し（～2021）France Patient Examination Devices Market Outlook to 2021 Summary GlobalData’s new report, "France Patient Examination Devices Market Outlook to 2021", provides key market data on the France Patient Examination Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Stethoscopes and Thermometers. The r …
- オメガ3系多価不飽和脂肪酸（PUFA）の世界市場：DHA、EPA、ALAThe market for Omega-3 PUFA is projected to reach USD 18.95 Billion by 2020, at a CAGR of about 13.8% from 2015 to 2020. The Omega-3 PUFA market is fueled by the growing health awareness among consumers and the increasing incidences of chronic conditions such as blood pressure, diabetes, cardiovascular disease, and cancer. Globally, the rise in aging populations and the growing health concerns has …
- 心臓モニタリング＆心調律管理デバイスの世界市場予測：CM別、CRM別、エンドユーザー別“Increasing prevalence of CVD to drive the growth of this market.”The cardiac monitoring and cardiac rhythm management devices market is projected to reach USD 25.0 billion by 2024 from USD 20.7 billion in 2019, at a CAGR of 3.9%. Growth in this market is primarily driven by the increasing incidence of cardiovascular diseases; technological advancements; increasing investments, funds, and grants f …
- 心臓血管情報システム（CVIS）の世界市場：カテーテル検査室、ECGデータ管理、心エコー検査室、血管検査室用途About Cardiovascular Information System A CVIS is a collection of research and clinical data gathered with the help of unique software, which facilitates information and support, and provides a complete medical record of patients in the cardiovascular field. The CVIS is used to endorse data with a high level of evidence-based quality. The CVIS improves patient safety and provides quality care by e …
- 世界のクラウド基盤企業コンテンツ管理市場動向（2012-2016）TechNavio’s analysts forecast the Global Cloud-based Enterprise Content Management market to grow at a CAGR of 24.3 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for reduced total cost of ownership. The Global Cloud-based Enterprise Content Management market has also been witnessing an emerging hybrid approach to cloud solutions. However, …
- グローバル化学市場におけるトップ10企業分析Synopsis The ICD Research Global Top 10 Chemical Companies: Company Guide is a crucial resource for anyone looking to gain information on the top companies in the global chemical industry. Detailed company profile and SWOT analysis information is provided for all the leading companies who are ranked in order by total annual revenues generated. BASF SE The Dow Chemical Company Saudi Basic Industrie …
- 天然ガス貯蔵の世界市場：地上貯蔵、地下貯蔵About Natural Gas Storage Natural gas storage involves accumulation of natural gas in several storage facilities for future consumption. The purpose of storage is to meet the fluctuating energy demand during the peak and off-peak seasons. Generally, natural gas is stored during the off-peak season and utilized during the peak season. This reduces the demand and supply gap, and increases the reliab …
- ペネトレーションテスト（侵入テスト）の世界市場予測（～2021）The penetration testing market size is expected to grow from USD 594.7 Million in 2016 to USD 1,724.3 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 23.7% during the forecast period. The major growth drivers of the market include the increased sophistication level in attacking techniques, and the need to meet compliance requirements. The penetration testing market is segmented by test …
- Canadian Oil Sands Limited：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Canadian Oil Sands Limited Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Canadian Oil Sands Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essent …
- トルコの発電市場2016：市場動向、制度、競争状況Turkey Power Market Outlook to 2030, Update 2016 - Market Trends, Regulations, and Competitive Landscape Summary This report elaborates Turkey's power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the Turkey power market’s regulatory structure, import and export trends, competitive landscape, and power projec …
